MX9703626A - Metodo para fabricar un medicamento para tratar la inmunodeficiencia secundaria. - Google Patents

Metodo para fabricar un medicamento para tratar la inmunodeficiencia secundaria.

Info

Publication number
MX9703626A
MX9703626A MX9703626A MX9703626A MX9703626A MX 9703626 A MX9703626 A MX 9703626A MX 9703626 A MX9703626 A MX 9703626A MX 9703626 A MX9703626 A MX 9703626A MX 9703626 A MX9703626 A MX 9703626A
Authority
MX
Mexico
Prior art keywords
medicament
making
treating secondary
secondary immunodeficiency
lymphocytes
Prior art date
Application number
MX9703626A
Other languages
English (en)
Other versions
MXPA97003626A (es
Inventor
John W Hadden
Original Assignee
Univ South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ South Florida filed Critical Univ South Florida
Publication of MX9703626A publication Critical patent/MX9703626A/es
Publication of MXPA97003626A publication Critical patent/MXPA97003626A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/515—CD3, T-cell receptor complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/59—Lectins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un método para producir una mezcla de citocina natural se describe incluyendo las etapas de inmovilizar por lo menos un nitrogeno en un recipiente de cultivo de tejido. Una poblacion aislada de linfocitos libres de neutrofilos y eritrocitos, se suspende en medios sin suero y se coloca en el recipiente. Los linfocitos son cultivados, los medios retirados y caracterizados para la produccion de citocinas.
MXPA/A/1997/003626A 1994-11-17 1997-05-16 Metodo para fabricar un medicamento para tratar la inmunodeficiencia secundaria MXPA97003626A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34164594A 1994-11-17 1994-11-17
US341645 1994-11-17

Publications (2)

Publication Number Publication Date
MX9703626A true MX9703626A (es) 1998-12-31
MXPA97003626A MXPA97003626A (es) 1999-02-01

Family

ID=

Also Published As

Publication number Publication date
DE69533941T2 (de) 2005-12-29
CA2205430A1 (en) 1996-05-30
EP0789588A1 (en) 1997-08-20
DE69533941D1 (de) 2005-02-24
EP0789588A4 (en) 2001-11-28
JP2007236395A (ja) 2007-09-20
US5698194A (en) 1997-12-16
AU4411196A (en) 1996-06-17
WO1996015808A1 (en) 1996-05-30
ES2236719T3 (es) 2005-07-16
JP2005245455A (ja) 2005-09-15
EP0789588B1 (en) 2005-01-19
JPH10510147A (ja) 1998-10-06
DK0789588T3 (da) 2005-05-30
JP2009209164A (ja) 2009-09-17
JP4440342B2 (ja) 2010-03-24
CA2205430C (en) 2001-09-04
PT789588E (pt) 2005-05-31
AU694304B2 (en) 1998-07-16
ATE287270T1 (de) 2005-02-15

Similar Documents

Publication Publication Date Title
EP0789588A4 (en) PROCESS FOR THE MANUFACTURE OF A DRUG FOR THE TREATMENT OF SECONDARY IMMUNODEFICIENCY
AU7769887A (en) Apparatus and methods of culturing motile microorganisms
AU580494B2 (en) Process for the extraction and purification of proteins from culture media producing them
EP0239697A3 (en) Apparatus for growing tissue cultures in vitro
CA1267623C (en) CELL CULTURE FILTER APPARATUS AND METHOD OF USE
AU7873187A (en) Method of culturing leukocytes
ZA88447B (en) Process for production of b avermectins and cultures therefor
KR960009482B1 (en) Method for preserving transplantable sheets of epithelium cultured in vitro
AU4277689A (en) Process for producing cultured epidermal sheet, product and method of use
EG18796A (en) Process for production of avermectins and cultures therefor.
AU5168490A (en) A method for culturing of cells on a membrane
EP0340783A3 (en) Apparatus for culturing animal cells, method of culturing thereof and diagnostics of the culture
EP0362408A4 (en) Method of culturing plant organs and culture vessel therefor
DE3364657D1 (en) Process and apparatus for culture of microorganisms using oxygen-enriched gas
EP0201800A3 (en) A cholesterol-rich fraction, process therefor and use thereof in cell culture
NZ232641A (en) Serum-free tissue culture medium and a method of culturing mammalian cells
HUT37648A (en) Process for producing auxotroph tissue culture and herbicideresistant plants
EP0117486A3 (en) Method for growth and purification of human cell lines from heterogeneous cell populations in tissue culture
EP0299067A4 (en) BREEDING MEDIUM FOR PLANTS.
JPS6437282A (en) Method and apparatus for culture of microorganism
EP0247881A3 (en) Process for culturing animal cells and appropriate media
ZA902088B (en) Process for lysing cells of microorganisms
NZ225577A (en) Operating biomass culture under sterile conditions and apparatus
AU631651B2 (en) Method for culturing cells
IL78345A0 (en) Process and apparatus for plant tissue culture propagation